CEO Drew Hykes attributes Q4's robust revenue growth to healthy VTE procedure volumes, emerging therapies' traction, and strong international performance. He also highlights progress across all RCTs and the U.S. launch of LimFlow, emphasizing commitment to strong growth and operating profitability.
The appointment of Rhonda Robb, with her extensive experience and proven track record, is expected to lead Okami Medical into its next phase of expansion and growth, particularly as the company prepares to commercialize its LOBO Vascular Occlusion System.
The increased insider selling of Inari Medical stock over buying in the last three months along with the year-long trend of insider transactions indicate caution despite high insider ownership. Company risk factors should also be considered alongside insider behavior.
The future looks bleak with predicted negative returns; current investors should consider de-risking. For potential investors, a negative growth outlook raises the risk of holding the Inari Medical stock. Careful examination of further insights and warning signs is advised before investing.
Gainers -$インドネシア・エネルギー(INDO.US)$+26.3% (announces that the company has mobilized the drilling rig to drill 2 back-to-back producing wells at its 63000-acre Kruh Block) -$クラウドストライク(CRWD.US)$+11.9% (fiscal 2023 outlook handily beats) -$ナテラ(NTRA.US)$+11.4% (to host special investor call in response to "misleading short seller report" on March 10 at 7 a.m. ET) -$マルケタ(MQ.US)$+9.8% (soars after earnings as outlook tops...
イナリ・メディカルに関するコメント
コラムTop upgrades and downgrades on 6/21: XOM, ADBE, UAA, BEKE and more
• $ABMインダストリーズ(ABM.US)$ : Baird Upgrades to Outperform from Neutral - PT $50
• $アメリカン・タワー(AMT.US)$ : JPMorgan Upgrades to Overweight from Underweight - PT $285 (from $245)
• $チャーチ・アンド・ドワイト(CHD.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $95
• $チューイー(CHWY.US)$ : Wedbush Upgrades to Outperform from Neutral - PT $35 (from $30)
• $センティーン(CNC.US)$ : Credit Suisse Upgrades to Outperform from...
Time to buy - support levels strong
コラムToday's pre-market stock movers: AMZN, AAPL, MA, CVX and more
• $GTY Technology(GTYH.US)$ +118.1% (entered into a definitive agreement to be acquired by GI Partners )
• $フィンチ・セラピューティクス(FNCH.US)$ +68.33% (announces removal of FDA clinical hold on CP101 IND)
• $ザイムワークス(ZYME.US)$ +42.34% (confirms receipt of non-binding proposal from All Blue Falcons for $10.50 per share in cash)
• $ハブ・グループ(HUBG.US)$ +16.3% (earnings reports)
• $ランセウス・ホールディングス(LNTH.US)$ +14.2% (earnings reports)
• $モホーク・インダストリーズ(MHK.US)$ +13.7% (e...
コラムToday's pre-market stock movers: AMZN, SONY, INDO, CRWD and more
- $インドネシア・エネルギー(INDO.US)$ +26.3% (announces that the company has mobilized the drilling rig to drill 2 back-to-back producing wells at its 63000-acre Kruh Block)
- $クラウドストライク(CRWD.US)$ +11.9% (fiscal 2023 outlook handily beats)
- $ナテラ(NTRA.US)$ +11.4% (to host special investor call in response to "misleading short seller report" on March 10 at 7 a.m. ET)
- $マルケタ(MQ.US)$ +9.8% (soars after earnings as outlook tops...
Tax Documents
まだコメントはありません